Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-23-002197
Filing Date
2023-11-27
Accepted
2023-11-27 16:30:41
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e5240_10k.htm   iXBRL 10-K 2175259
2 EXHIBIT 14.1 e5240_ex14-1.htm EX-14.1 154038
3 EXHIBIT 21.1 e5240_ex21-1.htm EX-21.1 2670
4 EXHIBIT 23.1 e5240_ex23-1.htm EX-23.1 2511
5 EXHIBIT 23.2 e5240_ex23-2.htm EX-23.2 3583
6 EXHIBIT 31.1 e5240_ex31-1.htm EX-31.1 17617
7 EXHIBIT 31.2 e5240_ex31-2.htm EX-31.2 17088
8 EXHIBIT 32.1 e5240_ex32-1.htm EX-32.1 8905
9 EXHIBIT 97.1 e5240_ex97-1.htm EX-97.1 36412
10 GRAPHIC image_001.gif GRAPHIC 25732
11 GRAPHIC image_002.gif GRAPHIC 23282
  Complete submission text file 0001731122-23-002197.txt   6316302

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE avxl-20230930.xsd EX-101.SCH 35227
13 XBRL CALCULATION FILE avxl-20230930_cal.xml EX-101.CAL 33039
14 XBRL DEFINITION FILE avxl-20230930_def.xml EX-101.DEF 98864
15 XBRL LABEL FILE avxl-20230930_lab.xml EX-101.LAB 256282
16 XBRL PRESENTATION FILE avxl-20230930_pre.xml EX-101.PRE 195832
52 EXTRACTED XBRL INSTANCE DOCUMENT e5240_10k_htm.xml XML 816477
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 231440632
SIC: 2836 Biological Products, (No Diagnostic Substances)